Search

everythinglearnresearchcommunity

for

Search:↓

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

Too much androgen can cause hair loss; finasteride may help.

A20 protein is crucial for normal skin and hair development.

The new assay can track and measure melanosome transfer between skin cells, confirming filopodia's role in this process.

Melatonin affects mouse skin and may regulate skin functions.

Testosterone is crucial for development, growth, and various body functions in mammals.

Most patients experience temporary hair loss after ECMO, but it usually grows back within 6 months without treatment.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

PRP shows promise in tissue repair but its effectiveness in otolaryngology is still debated.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

The vitreous membrane in hair follicles changes shape during the hair cycle and may affect hair growth and nutrient exchange.

Cutaneous lupus can cause permanent hair loss by damaging hair follicles.

Ferulic acid helps stabilize vitamins C and E for better skin protection from the sun, certain compounds may promote hair growth, atopic dermatitis patients have lower skin defense molecules, older men are more likely to get a type of skin cancer, and a substance called relaxin may prevent age-related skin thickening.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

KX-826 is safe and effectively increases hair count in men with hair loss.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

The guideline provides recommendations for managing alopecia areata effectively.

The treatment was ineffective in humans.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Disease-specific tools better assess quality of life in alopecia areata patients.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Both Betasalic ointment and 5% minoxidil are effective and safe for treating Alopecia Areata.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.